Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Description

List of Tables

The global autoimmune disease diagnostics market size is expected to reach USD 7,146.32 million by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The autoimmune disease diagnostics market is a sector within the healthcare and diagnostic industry. The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.

The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.

In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.

The autoimmune disease diagnostics market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.

In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the autoimmune disease diagnostics market growth.

Autoimmune Disease Diagnostics Market Report Highlights

Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.

The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.

A few global key market players are Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

Consumables and Assay Kits
Instruments

By Type Outlook (Revenue - USD Million, 2020-2034)

Systemic Autoimmune Disease Diagnostics
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others
Localized Autoimmune Disease Diagnostics
Multiple Sclerosis
Type 1 Diabetes
Hashimoto's Thyroiditis
Idiopathic Thrombocytopenic Purpura
Others

By Test Type Outlook (Revenue - USD Million, 2020-2034)

Antinuclear Antibody (ANA) Tests
Autoantibody Tests
Complete Blood Count (CBC)
Comprehensive Metabolic Panel
C-Reactive Protein (CRP)
Others

By End User Outlook (Revenue - USD Million, 2020-2034)

Hospitals
Diagnostics Centers
Research Laboratories

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Vietnam
Malaysia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM1299

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Autoimmune Disease Diagnostics Market Insights

4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
4.2. Autoimmune Disease Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increased Awareness and Screening Programs
  - 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
4.3. Restraints and Challenges
4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers (Moderate)
- 4.4.2. Threats of New Entrants (Low)
- 4.4.3. Bargaining Power of Buyers (Moderate)
- 4.4.4. Threat of Substitute (Moderate)
- 4.4.5. Rivalry Among Existing Firms (High)
4.5. PESTEL Analysis
4.6. Autoimmune Disease Diagnostics Market Type Trends
4.7. Value Chain Analysis
4.8. COVID-19 Impact Analysis

5. Global Autoimmune Disease Diagnostics Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
5.3. Consumables and Assay Kits
- 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2020-2034 (USD million)
5.4. Instruments
- 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2020-2034 (USD million)

6. Global Autoimmune Disease Diagnostics Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
6.3. Systemic Autoimmune Disease Diagnostics
- 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.3.2. Rheumatoid Arthritis
  - 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD million)
- 6.3.3. Ankylosing Spondylitis
  - 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2020-2034 (USD million)
- 6.3.4. Systemic Lupus Erythematosus (SLE)
  - 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2020-2034 (USD million)
- 6.3.5. Others
  - 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
6.4. Localized Autoimmune Disease Diagnostics
- 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.4.2. Multiple Sclerosis
  - 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
- 6.4.3. Type 1 Diabetes
  - 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2020-2034 (USD million)
- 6.4.4. Hashimoto's Thyroiditis
  - 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2020-2034 (USD million)
- 6.4.5. Idiopathic Thrombocytopenic Purpura
  - 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2020-2034 (USD million)
- 6.4.6. Others
  - 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Autoimmune Disease Diagnostics Market, by Test Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
7.3. Antinuclear Antibody (ANA) Tests
- 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2020-2034 (USD million)
7.4. Autoantibody Tests
- 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2020-2034 (USD million)
7.5. Complete Blood Count (CBC)
- 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2020-2034 (USD million)
7.6. Comprehensive Metabolic Panel
- 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2020-2034 (USD million)
7.7. C-Reactive Protein (CRP)
- 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2020-2034 (USD million)
7.8. Others
- 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Autoimmune Disease Diagnostics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
8.3. Hospitals
- 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD million)
8.4. Diagnostics Centers
- 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2020-2034 (USD million)
8.5. Research Laboratories
- 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2020-2034 (USD million)

9. Global Autoimmune Disease Diagnostics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD million)
9.3. Autoimmune Disease Diagnostics Market - North America
- 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.5. Autoimmune Disease Diagnostics Market - US
  - 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.6. Autoimmune Disease Diagnostics Market - Canada
  - 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.4. Autoimmune Disease Diagnostics Market - Europe
- 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.5. Autoimmune Disease Diagnostics Market - UK
  - 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.6. Autoimmune Disease Diagnostics Market - France
  - 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.7. Autoimmune Disease Diagnostics Market - Germany
  - 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.8. Autoimmune Disease Diagnostics Market - Italy
  - 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.9. Autoimmune Disease Diagnostics Market - Spain
  - 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
  - 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.11. Autoimmune Disease Diagnostics Market - Russia
  - 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.5. Autoimmune Disease Diagnostics Market - China
  - 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.6. Autoimmune Disease Diagnostics Market - India
  - 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
  - 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.8. Autoimmune Disease Diagnostics Market - Japan
  - 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
  - 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
  - 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.11. Autoimmune Disease Diagnostics Market - Australia
  - 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.6. Autoimmune Disease Diagnostics Market - UAE
  - 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.7. Autoimmune Disease Diagnostics Market - Israel
  - 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
  - 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.7. Autoimmune Disease Diagnostics Market - Latin America
- 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
  - 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
  - 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
  - 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. AESKU.DIAGNOSTICS
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Beckman Coulter, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. BIOMERIEUX
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Bio-Rad Laboratories, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. EUROIMMUN
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. F. Hoffmann-La Roche Ltd
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Inova Diagnostics (Werfen Group)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Myriad Genetics, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Quest Diagnostics
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Scipher Medicine
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Siemens Healthcare Private Limited
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Thermo Fisher Scientific Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development